Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.
about
Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisVolasertib for AML: clinical use and patient considerationMolecular therapy for acute myeloid leukaemia.Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification.The value of molecular stratification for CEBPA(DM) and NPM1(MUT) FLT3(WT) genotypes in older patients with acute myeloid leukaemiaCorrelation of NPM1 Type A Mutation Burden With Clinical Status and Outcomes in Acute Myeloid Leukemia Patients With Mutated NPM1 Type A.Treatment ethics, quality of life and health economics in the management of hematopoietic malignancies in older patients.Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia.TP53 mutations in older adults with acute myeloid leukemia.Incidence and outcomes for adults diagnosed with acute myeloid leukemia in the north of England: a real world study.Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia.Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status.Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia.Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia.Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report.Long-term outcome of NPM1 mutated acute myeloid leukemia: A single-institution experience.Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies.The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia.Genetic alterations and their clinical implications in older patients with acute myeloid leukemia.mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agentsMolecular landscape and targeted therapy of acute myeloid leukemiaWhen to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
P2860
Q26797245-65807ED2-7B39-4DE0-9631-B62562D414A9Q26801131-678BEE89-9C06-4033-98A0-A8A2CEA82E63Q33925672-DEBA9E28-88C7-4C4C-B3D8-89A2AD1D983DQ36849666-9E49C5DA-5672-415A-A094-6431D8465339Q36866323-32BDA100-2ADF-4E94-B384-2E722651AE6CQ37084121-0AF43204-7710-4A21-A7AF-BED57ED320BAQ38520091-3D74E1B6-0A25-43F7-8906-8D09DA5B929FQ38963613-7C586CF2-64A5-4DA6-B28D-B67864FA9D43Q40967841-58325370-2299-4EE0-9F78-14A58E302B4EQ41051992-7B5B35DE-9541-424D-B185-043BEF6BC1B8Q41616680-97449D4A-5E3A-4CCC-9A9F-62BD7701F94BQ43108999-7A728578-D111-4B14-88ED-69EC99AFEED7Q48121119-B56AC2EC-C416-491A-AB98-8223E37A4AC3Q48363222-2A28C525-8F9D-4602-AB83-F3CDB379415AQ48568744-DACA6A84-AF84-42D4-93B5-019EA8CDE78DQ49668289-90349E99-664E-4231-83F2-F97422A04383Q51344960-BD9BA775-559C-434A-8144-70E2FB879BF7Q52347210-BD001C4E-DFE4-4AB0-A8F2-0903B6F82245Q54300663-48EE9A69-10F9-4B69-AFF8-4503413EF496Q55025720-2BD77F8E-5489-4A85-BA36-45483F1A9D06Q58793786-532339B6-A0D7-4F7F-83B1-CE54D1066A9EQ59130314-C3B9CCAD-3FF8-43DD-8AE6-B8B04FB39D7CQ59133388-28DD9CEF-E174-4C5B-8B73-67E575D69D83
P2860
Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Prognostic significance of NPM ...... dical Research Council report.
@ast
Prognostic significance of NPM ...... dical Research Council report.
@en
type
label
Prognostic significance of NPM ...... dical Research Council report.
@ast
Prognostic significance of NPM ...... dical Research Council report.
@en
prefLabel
Prognostic significance of NPM ...... dical Research Council report.
@ast
Prognostic significance of NPM ...... dical Research Council report.
@en
P2093
P2860
P50
P356
P1476
Prognostic significance of NPM ...... dical Research Council report.
@en
P2093
Alan Burnett
Alan F List
Amanda Gilkes
Anna Evans
Cheryl L Willman
Derek L Stirewalt
Elihu Estey
Era L Pogosova-Agadjanyan
Fabiana Ostronoff
Jerald P Radich
P2860
P304
P356
10.1200/JCO.2014.58.0571
P407
P577
2015-02-23T00:00:00Z